JUBILANT PHARMOVA
|
|
BOM : 530019     NSE : JUBLPHARMA     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : NA |
Feb 08,2023 |
Price(EOD): ₹ 328.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 5,233.80 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
JUBILANT PHARMOVA | -5.6% | -8.8% | -36.7% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -0.1% | 12.5% |
DIVIS LABORATORIES | -14.3% | -19.1% | -36.2% |
CIPLA | 1.4% | -4.4% | 9% |
DR REDDYS LABORATORIES | 2.7% | 3.5% | 2.1% |
TORRENT PHARMACEUTICALS | 1% | -0.4% | 14.4% |
ABBOTT INDIA | 3.8% | -4.4% | 32% |
ZYDUS LIFESCIENCES | 9.6% | 7% | 17.2% |
ALKEM LABORATORIES | 3.4% | 4.1% | -12.8% |
FUNDAMENTAL ANALYSIS OF JUBILANT PHARMOVA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JUBILANT PHARMOVA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
53.49
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 97.84 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 0.98
P/B Calculated based on Book Value of Rs 5,314.90 Cr
[Latest Year - Mar2022 - Consolidated Results ] 0.85
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 6,131.26 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-33% -40% -38% |
SHARE PRICE MOMENTUM OF JUBILANT PHARMOVA
JUBILANT PHARMOVA vs SENSEX
DEBT OF JUBILANT PHARMOVA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.39 0.38 0.75 0.51 |
0.55 0.55 0.83 0.64 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF JUBILANT PHARMOVA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF JUBILANT PHARMOVA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-2.94% -33.31% -73.43% -289.84% |
18.46% -24.9% -85.21% -128.34% |
QtrlyTrend |
-6 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
JUBILANT PHARMOVA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 400 MIDSMALLCAP | 1.5% | -1.1% | -1.6% |
S&P BSE MIDSMALLCAP | 1.5% | -1.6% | -3.1% |
S&P BSE 500 | 1.2% | -1.7% | -0.6% |
S&P BSE ALLCAP | 1.2% | -1.8% | -0.8% |
S&P BSE 250 SMALLCAP | 1.1% | -1.4% | -6% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 1.4% | -1.5% | -1.8% |
NIFTY 500 | 1.2% | -1.6% | -0.7% |
NIFTY500 MULTICAP 50:25:25 | 1.2% | -1.6% | -1.9% |
NIFTY SMALLCAP250 | 0.7% | -2% | -8.2% |
You may also like the below Video Courses
FAQ about JUBILANT PHARMOVA
Is JUBILANT PHARMOVA good for long term investment?
As on Feb 08,2023, the Fundamentals of JUBILANT PHARMOVA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of JUBILANT PHARMOVA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JUBILANT PHARMOVA UnderValued or OverValued?
As on Feb 08,2023, JUBILANT PHARMOVA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JUBILANT PHARMOVA ?
As on Feb 08,2023, the Intrinsic Value of JUBILANT PHARMOVA is Rs. 531.63 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 488.30
Fair Value [Median EV / Sales Model] : Rs. 544.46
Fair Value [Median Price / Sales Model] : Rs. 531.63
Estimated Median Fair Value of JUBILANT PHARMOVA : Rs. 531.63
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is JUBILANT PHARMOVA trading at a Premium or Discount?
As on Feb 08,2023, JUBILANT PHARMOVA is trading at a Discount of -38% based on the estimates of Median Intrinsic Value!